๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Second primary tumors after prostate carcinoma

โœ Scribed by Fabio Levi; Lalao Randimbison; Van-Cong Te; Georges Erler; Carlo La Vecchia


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
65 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Several large datasets have shown a reduced risk of all neoplasms after a diagnosis of prostate carcinoma but an increased incidence rate of urologic carcinoma has been suggested.


๐Ÿ“œ SIMILAR VOLUMES


Cyclin D1 expression in human prostate c
โœ Han, Edward Kyu-Ho; Lim, Jin T.E.; Arber, Nadir; Rubin, Mark A.; Xing, Wang Qiu; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 307 KB ๐Ÿ‘ 2 views

## BACKGROUND. The cyclin D1 gene is amplified and/or overexpressed in several types of human cancer, including cancers of the breast, esophagus, head, and neck. However, the role of cyclin D1 in prostate cancer has not been previously studied in detail. METHODS. Six human prostate cancer cell lin

Second malignancies in prostate carcinom
โœ David J. Brenner; Rochelle E. Curtis; Eric J. Hall; Elaine Ron ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 2 views

## BACKGROUND. In the treatment of prostate carcinoma, radiotherapy and surgery are common choices of comparable efficacy; thus a realistic comparison of the potential long term sequelae, such as the risk of second malignancy, may be of relevance to treatment choice. ## METHODS. Data regarding th

Second primary cancers of endometrial ca
โœ Vitune Vongtama; Samuel S. Kurohara; Ahmed O. Badib; John H. Webster ๐Ÿ“‚ Article ๐Ÿ“… 1970 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 325 KB ๐Ÿ‘ 2 views

Of 984 patients with corpus cancer treated at Roswell Park Memorial Institute (between 1940 and 1960), 116 (11.8%) were found to have second primaries; of these, 47 had breast cancer, 15 skin cancer, 27 other pelvic cancers, 15 abdominal cancer, 3 head and neck cancer, and 3 lymphoma or leukemia. T

Very frequent p53 mutations in metastati
โœ Frederick J. Meyers; Paul H. Gumerlock; Sung Gil Chi; Holger Borchers; Arline D. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 1 views

## BACKGROUND. The frequency of mutant p53 in bone marrow metastases of patients with carcinoma of the prostate (CaP) and in matched sets of metastatic and primary lesions from the same patients was investigated. The data were examined in relation to prior treatment with androgen ablation (AA) the